<p>The process for the preparation of the vaccine entails a hepatitis A virus obtained from human material being passaged fifteen to thirty times in human cells. A vaccine containing a virus cultivated in this way is preferably suitable for oral administration.</p>
申请公布号
FI874276(A0)
申请公布日期
1987.09.30
申请号
FI19870004276
申请日期
1987.09.30
申请人
BEHRINGWERKE AKTIENGESELLSCHAFT
发明人
GREGERSEN, JENS-PETER;NOLL, GABRIELE;MAULER, RUDOLF
